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Abstract
Considerable effort has been dedicated to the development of technology for the site-specific
incorporation of unnatural amino acids into proteins, with nonsense codon suppression and
expressed protein ligation emerging as two of the most promising methods. Recent research
advances in which these methods have been applied to study protein function and mechanism are
briefly highlighted, and the potential of the methods for efficient, widespread future use in vitro and
in vivo is critically evaluated.
Introduction and context
Robust technology has the potential to revolutionize
scientific inquiry in ways often unimaginable at the time
of the method’s infancy. In the fields of protein
chemistry and enzymology, an example of such a
technology is site-directed mutagenesis, which allows
researchers to site-specifically replace any naturally
occurring amino acid with another amino acid in the
genetic code [1]. The technology of site-directed muta-
genesis evolved over several decades and is now used
routinely by scientists across many disciplines to address
diverse questions related to protein structure and
function. The ability to site-specifically replace any
natural amino acid with an unnatural amino acid
(UAA) has even greater potential for protein biochem-
istry, as it allows the introduction of unique chemical
properties and reactivities into the protein environment.
Recent advances in this field suggest that the tools to
achieve this goal, once developed to their full potential,
will also facilitate solving problems that cannot be
addressed by current methods [2]. This technology will
be transforming.
Two general approaches are currently available to replace
natural amino acids with unnatural analogues: in vitro or
in vivo nonsense-codon suppressor tRNA technology and
expressed protein ligation (EPL) technology. Recent
advances in these two methods have been reviewed
thoroughly by pioneers in the respective fields, Peter
Schultz and Tom Muir [3-6]. In the former technique
(Figure1),atRNAwithasuppressoranticodon ischarged
with a UAA and incorporates it site-specifically during
mRNA translation in response to a nonsense codon
placed site-specifically in a gene of interest. Exploitation
of Nature’s translational machinery, the ribosome,in this
way has allowed for incorporation of more than 100
UAAs into a wide variety of proteins in a number of
model organisms. Incorporation by this method is
astonishing, as Nature has evolved many mechanisms
to ensure fidelity of the translational process [7,8]. The
most efficient means of charging the tRNA with the UAA
is an area of intense research. The method pioneered by
Schultz allows for in vivo tRNA charging via the evolution
of an orthogonal tRNA synthetase (RS) [9] and has
proven successful in many proof-of-concept studies [4].
Invitro attachmentoftheUAAtothetRNAby chemical or
enzymatic synthesis has also proven to be a viable
alternative in select systems [10].
The foundation of EPL lies in intein-mediated protein
self-splicing [11]. Coupling this naturally occurring
phenomenon with the synthetic technique of native
chemical ligation [12] has allowed for the semisynthesis
of proteins containing UAAs by a combination of
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(Figure 2). While the original rendition of this method
necessitated additional point mutations beyond the UAA
of interest, this problem has been addressed by recent
efforts in the development of traceless ligations [13,14].
It is important to highlight that, in addition to the two
well-established methods described herein, there exist
many emerging technologies for UAA incorporation.
Noteworthy examples include reconstituted, cell-free
translation systems [15] and flexizyme technology
[16,17]. While both show promise for the simultaneous
incorporation of multiple different UAAs with high
fidelity, these technologies are presently limited to
synthesis of peptides and are not yet suitable for
incorporation of UAAs into large proteins. Thus, these
methods, while promising, are not discussed at length in
this brief review.
Major recent advances
As the methods described above are evolving, a rapidly
increasing number of protein studies involving UAAs are
being reported. Below, three studies are highlighted in
which UAA incorporation has provided a unique
opportunity to address mechanistic questions.
Over the past 10 years, ion channels and receptors have
been a particularly interesting target for UAA incorpora-
tion. By microinjection of in vitro-charged tRNAs and
mRNA bearing a nonsense codon, Dougherty, Lester and
coworkers have conducted whole-cell electrophysiologi-
cal studies in Xenopus oocytes probing the activation of
ion channels of the Cys-loop superfamily [10]. Site-
specific incorporation of a series of fluorinated tyrosine
or tryptophan analogues at conserved aromatic amino
acids in the agonist binding sites of GABAc (g-aminobu-
tyric acid receptor C) and nicotinic acetylcholine
receptors, respectively, revealed the importance of
cation-p interactions in agonist binding [18,19]. The
success of UAA studies in ion channels/receptors is
intricately linked to the sensitivity of electrophysiology
techniques, which has allowed measurable readout in
cells containing only small amounts of the mutant
proteins. Recently, nonsense codon suppression has
been extended to study the activation of G-protein-
coupled receptors (GPCRs). Thirteen UAAs were incor-
porated into the M2 muscarinic acetylcholine and D2
dopamine GPCRs via microinjection of charged tRNAs
into Xenopus cells, and the role of specific residues in
ligand binding was assessed by an optimized assay in
which activation of a downstream G-protein-coupled K
+
channel was monitored electrophysiologically [20].
Interestingly, GPCRs in yeast have also been targeted
recently for UAA studies. Incorporation of the photo-
activatable amino acid p-benzoyl-L-phenylalanine (Bpa)
into the ligand-binding site of the Saccharomyces cerevisiae
GPCR Ste2p was demonstrated using an evolved,
orthogonal tRNA-RS pair specific for Bpa [21]. Photolysis
of the mutant protein resulted in the capture of Ste2p
with its a factor ligand.
The use of EPL has contributed significantly to under-
standing structure-function relationships in ion channels
as well. High-resolution crystal structures of the potas-
sium channel KcsA led to the hypothesis that the
channel’s ion selectivity was derived from backbone
carbonyl groups that lined the pore, or selectivity filter,
region of this integral membrane protein [22]. By EPL,
Muir and colleagues [23] reported the semisynthesis of a
truncated KcsA in which the amino-terminal 73 amino
acids were expressed recombinantly and the carboxy-
terminal 52 residues, which encompass the entire
selectivity filter, were generated by solid-phase peptide
Figure 1. Unnatural amino acid incorporation though nonsense
codon suppression
An evolved tRNA containing a nonsense anticodon is charged in vitro or
in vivo with an unnatural amino acid. The machinery of the ribosome
recognizes a nonsense codon within the mRNA, site-specifically engineered
into the gene of interest, and uses the charged tRNA to site-specifically
incorporate the unnatural amino acid into the protein.
Figure 2. Expressed protein ligation (EPL)
The amino-terminal peptide of the target protein is expressed in vivo as a
fusion protein with an intein that has been modified to eliminate the
branched ligation. Thiols (R = benzyl, phenyl, alkyl, CH2CH2SO3Na) are
used to cleave the intein and generate a reactive carboxy-terminal thioester.
This construct is then reacted with a peptide generated by solid phase
peptide synthesis that contains an amino-terminal cysteine and an unnatural
amino acid(s) in the position of interest. Reaction between the two
constructs results in thiotransesterification, followed by S to N acyl shift to
regenerate a peptide. There are many variations on this general theme.
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which D-amino acids were introduced in the selectivity
filter to report on the role of a left-handed helix in
mediating ion conductivity. Likewise, semisynthetic
channels with amide-to-ester backbone mutations pro-
vided insight into how the energetics of different binding
configurations contribute to maintaining an optimized
ion current [24].
Both nonsense suppression and EPL methods have been
utilized in mechanistic studies of the class Ia ribonucleo-
tide reductases (RNRs). RNRs catalyze the reduction of
all four nucleotides to their 2
0-deoxy analogues, and thus
play a key role in modulating the relative ratios and
absolute amounts of deoxynucleotide pools necessary
for DNA synthesis and repair. Class Ia RNRs utilize a
unique mechanism of long-range proton-coupled elec-
tron transfer (PCET) through transient aromatic amino
acid radicals to generate an active site protein radical,
which then initiates substrate reduction. This oxidation
occurs over 35 Å and through two protein subunits, and
is proposed to involve the participation of three tyrosines
that act as oxidation ‘stepping stones’ [25,26]. Initial
studies focused on the participation of Y356, located in
the conformationally flexible carboxy-terminal tail of
one of the subunits (b). Because of its location in the
protein (residue 356 of 375 amino acids), this tyrosine
was targeted for UAA replacement via EPL. To date, more
than a half-dozen UAAs with varying reduction poten-
tials and pKas have been incorporated into the b subunit
made semisynthetically to examine the role of Y356 in
long-range PCET [27-29]. Two additional tyrosines
implicated in this mechanism are Y730 and Y731 of the
second subunit (a). These have been the successful target
of site-specific UAA incorporation via the in vivo
orthogonal tRNA-RS nonsense suppression method
[2,30]. Two UAAs, the redox trap 3-aminotyrosine and
the pKa probe 3-nitrotyrosine, have been incorporated at
positions 730 and 731, with isolation of the mutant
proteins occurring on the 100 mg scale. The incorpora-
tion of these UAAs will allow for the unprecedented
study of the mechanism of PCET, previously inaccessible
due to a rate-limiting conformational change in wild-
type RNR.
Future directions
While all methods have certain niches in which they
prove most useful for problem solving,in our opinion, in
vivo nonsense suppression is the method that demon-
strates the most potential for future development and
widespread applicability. Methodology development to
date has been most extensively focused on incorporation
of UAAs into proteins expressed in Escherichia coli. This is
no coincidence, as the bacterial translational machinery
is simpler and the details better understood than in
eukaryotic systems. Undoubtedly, as our understanding
of translation continues to expand in both prokaryotic
and eukaryotic systems, new methods will evolve to take
advantage of this knowledge.
Recent methods developed by Wang and Wang [31] to
increase expression levels of proteins containing UAAs in
S. cerevisiae provide a case in point. In this organism,
reported expression levels of UAA-containing proteins are
substantially lower than in E. coli expression systems.
Protein yields in the yeast-based expression systems were
increased significantly by improvements in the expression
efficiency of the orthogonal prokaryotic tRNA and the
intracellular stability of the nonsense codon-containing
mRNA. Similarly, order-of-magnitude improvements in
protein yields were reported for an expression system in
Pichia pastoris in which the genes encoding the orthogonal
tRNA-RS were incorporated into the organism’s genome
under the control of optimized promoters [32].
This technology would also benefit from a more efficient
means of evolving orthogonal tRNA-RS pairs for unique
UAAs. At present, selections using E. coli as the host
organism occur on the month timescale, typically
requiring four to six rounds of positive and negative
selection and a battery of control reactions. Recently,
Melançon and Schultz [33] described a single plasmid
selection system in which positive and negative selec-
tions were conducted via expression of one fusion gene,
thus eliminating the need for plasmid isolation and re-
transformation in between selection rounds and greatly
reducing the time and labor involved in RS evolution.
Improving the suppression efficiency of nonsense
codons has been the focus of recent work by the Chin
lab. One problem inherent to the in vivo nonsense
suppression method is the competition between mutant,
orthogonal tRNAs and endogenous release factors (RFs)
for interaction with the nonsense codon during mRNA
translation. This competition often results in high levels
of truncated proteins that can complicate purification of
proteins and biochemical analyses. Chin and coworkers
have reported the evolution of an orthogonal E. coli
ribosome optimized in the 530 loop of the 16s rRNA for
preferential interaction with the orthogonal tRNA over
RF-1 [34]. The ribosome translates an orthogonal,
nonsense codon-containing mRNA, identified by its
modified ribosomal binding site [35], with high
specificity and fidelity. This technology has been
demonstrated to increase suppression efficiency in
genes containing single nonsense codons by up to 3-
fold, and genes containing two nonsense codons by up
to 20-fold. These orthogonal ribosome-mRNA pairs
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orthogonal gene expression systems in E. coli [35,36].
Finally, evolution of a mutant orthogonal tRNA-RS pair
for expression in mammalian systems must be modified
relative to the E. coli selection scheme due to difficulty in
generating large, stable synthetase libraries and ineffi-
cient survival rates relative to prokaryotes in consecutive
selection rounds. The emerging strategy of a bacterial-
mammalian ‘shuttle’ shows promise in addressing this
issue. By this method, a pyrrolysyl tRNA-RS pair from the
mutually orthogonal organism Methanosarcina mazei was
evolved in the E. coli host and then transfected into
mammalian cells for protein expression [37].
Given the excitement expressed by the research commu-
nity for this technology and the increasing number of
young scientists dedicated to its development, the
methodology for robust, efficient incorporation of
UAAs into proteins is primed to evolve very rapidly in
the immediate future. We anticipate the day when ready-
to-use tRNA-RS pairs are at our disposal to tackle
biological problems both in vitro and in vivo.
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